Sector: Healthcare
findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for GEHC, sign up here.
Income Statement
Revenue
$19.6bn
Gross Profit
$7.9bn
Earning before Tax
$2.3bn
Net Income
$1.6bn
Net Income Common Shareholders
$1.4bn
EPS
3.06
Balance Sheet
Cash
$2.5bn
Debt
$9.4bn
Assets
$32.5bn
Liabilities
$25.1bn
Equity
$7.1bn
Enterprise Value
$43.0bn
Cash Flow Statement
Net Cash from Operations
$2.1bn
Net Cash from Investing
$-0.6bn
Net Cash from Financing
$-0.5bn
Net Cash Flow
$1.1bn
Free Cash Flow
$1.7bn
Free Cash Flow per Share
$3.77
Metrics
Price to Equity
25.41
Price to Equity (Damodaran)
25.27
Price to Book
4.93
Net Margin
0.07
Return on Equity
0.20
Return on Sales
0.15
Get immediate access to 5-years of reference grade data for GEHC for free.
Sign upGE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women''s health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women''s health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Company Info
Industry
Health Information Services
Employees
51,000
Address
500 West Monroe Street
Chicago, IL 60661
United States
Phone
833 735 1139
Website
Last Updated
2024-02-16
Available Data
Standardized Financial Statements
EOD Price History
Corporate Actions
Institutional Holdings
Insider Transactions
Copyright © findl 2024. All rights reserved.